126 related articles for article (PubMed ID: 17890276)
41. Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy.
Troedson C; Wong M; Dalby-Payne J; Wilson M; Dexter M; Rice GI; Crow YJ; Dale RC
Lupus; 2013 May; 22(6):639-43. PubMed ID: 23651859
[TBL] [Abstract][Full Text] [Related]
42. Hereditary C1q deficiency and secondary Sjögren's syndrome.
Hoppenreijs EP; van Dijken PJ; Kabel PJ; Th Draaisma JM
Ann Rheum Dis; 2004 Nov; 63(11):1524-5. PubMed ID: 15479911
[No Abstract] [Full Text] [Related]
43. [Congenital homozygotic complement deficiency and systemic diseases with skin manifestation: collagenoses and vasculitis].
Morel P; Civatte J
Z Hautkr; 1979 Jul; 54(13):625-32. PubMed ID: 483958
[No Abstract] [Full Text] [Related]
44. Studies of immune response in a patient with selective complete C1q deficiency.
Berkel AI
Turk J Pediatr; 1993; 35(3):221-6. PubMed ID: 8165758
[TBL] [Abstract][Full Text] [Related]
45. [The association of complement with common connective tissue diseases - a review].
Arason GJ
Laeknabladid; 2008 May; 94(5):371-4. PubMed ID: 18460733
[TBL] [Abstract][Full Text] [Related]
46. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
[TBL] [Abstract][Full Text] [Related]
47. Molecular basis of hereditary C1q deficiency.
Petry F
Immunobiology; 1998 Aug; 199(2):286-94. PubMed ID: 9777412
[TBL] [Abstract][Full Text] [Related]
48. Acquired C1q deficiency caused by monoclonal paraproteinaemia.
Gordon MM; Lucie N; Porter D
Lupus; 2000; 9(1):68-71. PubMed ID: 10713650
[TBL] [Abstract][Full Text] [Related]
49. A patient with hereditary C1q deficiency.
Ozsoylu S
Turk J Pediatr; 2010; 52(6):674; author reply 674. PubMed ID: 21428208
[No Abstract] [Full Text] [Related]
50. Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2.
Hong Y; Nanthapisal S; Omoyinmi E; Olbrich P; Neth O; Speckmann C; Lucena JM; Gilmour K; Worth A; ; Klein N; Eleftheriou D; Brogan P
Front Immunol; 2019; 10():2589. PubMed ID: 31781101
[TBL] [Abstract][Full Text] [Related]
51. Mode of inheritance in systemic lupus erythematosus in Saudi multiplex families.
Qari A; Al-Mayouf S; Al-Owain M
Genet Couns; 2009; 20(3):215-23. PubMed ID: 19852427
[TBL] [Abstract][Full Text] [Related]
52. A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation.
López-Lera A; Favier B; de la Cruz RM; Garrido S; Drouet C; López-Trascasa M
J Allergy Clin Immunol; 2010 Dec; 126(6):1307-10.e3. PubMed ID: 20864152
[No Abstract] [Full Text] [Related]
53. Identification of novel coding mutation in C1qA gene in an African-American pedigree with lupus and C1q deficiency.
Namjou B; Keddache M; Fletcher D; Dillon S; Kottyan L; Wiley G; Gaffney PM; Wakeland BE; Liang C; Wakeland EK; Scofield RH; Kaufman K; Harley JB
Lupus; 2012 Sep; 21(10):1113-8. PubMed ID: 22472776
[TBL] [Abstract][Full Text] [Related]
54. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
55. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
[TBL] [Abstract][Full Text] [Related]
56. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
57. Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency.
Berkel AI; Petry F; Sanal O; Tinaztepe K; Ersoy F; Bakkaloglu A; Loos M
Eur J Pediatr; 1997 Feb; 156(2):113-5. PubMed ID: 9039514
[TBL] [Abstract][Full Text] [Related]
58. Cerebellar ataxia in systemic lupus erythematosus.
Appenzeller S; Cendes F; Costallat LT
Lupus; 2008 Dec; 17(12):1122-6. PubMed ID: 19029281
[TBL] [Abstract][Full Text] [Related]
59. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
[TBL] [Abstract][Full Text] [Related]
60. The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease?
Senécal JL; Raymond Y
J Rheumatol; 2004 Nov; 31(11):2093-8. PubMed ID: 15517616
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
